aap

Successful start in 2015 with 45% LOQTEQ® sales increase and 23% growth in biomaterials business - Seite 2

Sustained by the significant growth in LOQTEQ® product sales, aap Implantate AG's overall sales in the trauma business rose year-on-year by 15% to EUR 2.5 million (Q1/2014: EUR 2.2 million). On a full year basis the company's target is to achieve sales growth of more than 20% in the trauma business. In order to achieve this target, aap Implantate AG intends to expand the LOQTEQ® product family further in the current financial year and thereby achieving an indication coverage of more than 90%. Furthermore the company plans to push the internationalisation with a focus on the US American market.

In the biomaterials business the company also achieved a significant sales increase in the first quarter of 2015. Sales grew in the reporting period compared to the first three months of financial year 2014 by 23% to EUR 4.4 million (Q1/2014: EUR 3.6 million). The growth driver in the first quarter of the current year was in particular the bone cement business with global leading companies.

Overall, it can be furthermore stated that aap Implantate AG generates dynamic sales growth and pushes geographic expansion with its innovative and IP protected LOQTEQ® products, while the biomaterials business is characterized by continuous and profitable growth with strong cash flows.

The preliminary results contained in this press release are based on management's initial analysis of operations for the period ended on 31 March 2015, and are therefore subject to change. aap Implantate AG plans to announce its final results for the first quarter of 2015 on 15 May 2015. 

About aap Implantate AG
aap is a global medical device company headquartered in Berlin, Germany that develops, manufactures and markets innovative biomaterials and implants that are used in orthopedic procedures. The Company's products, which include a full line of plating systems, cannulated screws and bone cement products, are primarily used in the orthopedic specialty areas of trauma and spine repair. The Company's products are sold through its direct sales force, distribution partners and license agreements with OEM partners. aap's stock is listed in the Prime Standard segment of the Frankfurt Stock Exchange. For more information, please visit www.aap.de, or download the Company's investor relations app from the Apple's App Store or Google Play.